XML 19 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net income $ 32,693 $ 13,787
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 4,271 5,285
Impairment charges and other 0 9,807
Amortization of marketable securities 31 316
Stock-based compensation 3,575 2,423
Deferred income taxes 4,978 5,594
Changes in operating assets and liabilities:    
Restricted cash (2,863) (1,112)
Accounts receivable (34,703) (84,662)
Prepaid insurance (4,137) (15,359)
Other current assets (11,313) (3,432)
Other assets (3,804) (1,642)
Accounts payable (168) (1,613)
Payroll taxes and other payroll deductions payable (3,038) 326
Accrued worksite employee payroll expense 105,739 31,168
Accrued health insurance costs (5,906) 7,260
Accrued workers’ compensation costs 8,761 5,360
Accrued corporate payroll, commissions and other accrued liabilities (9,465) (7,473)
Income taxes payable/receivable 10,556 (3,983)
Total adjustments 62,514 (51,737)
Net cash provided by (used in) operating activities 95,207 (37,950)
Marketable securities:    
Purchases (103) (3,964)
Proceeds from dispositions 7,268 824
Proceeds from maturities 790 2,620
Property and equipment:    
Purchases (4,880) (2,423)
Net cash provided by (used in) investing activities 3,075 (2,943)
Cash flows from financing activities:    
Purchase of treasury stock (4,768) (5,719)
Payments for Repurchase of Common Stock (144,263) 0
Dividends paid (4,652) (4,844)
Proceeds from the exercise of stock options 0 374
Income tax benefit from stock-based compensation 0 2,929
Borrowings under long-term debt agreement 124,400 0
Principal repayments (20,000) 0
Other 311 285
Net cash used in financing activities (48,972) (6,975)
Net increase (decrease) in cash and cash equivalents 49,310 (47,868)
Cash and cash equivalents at beginning of period 269,538 276,456
Cash and cash equivalents at end of period $ 318,848 $ 228,588